- https://twitter.com/OncologyAdvance
- http://www.elsevier.com/journals/gynecologic-oncology/0090-8258/open-access-options
- http://www.researcheracademy.com
- http://ees.elsevier.com/ygyno/
- http://www.myhealthtalent.com/
- http://www.elsmediakits.com/us/journals/oncology-hematology/gynecologic-oncology/YGYNO
- http://reprints.elsevier.com
- http://www.journals.elsevierhealth.com/periodicals/home
- http://www.elsevierhealth.com
- http://journalinsights.elsevier.com/journals/0090-8258
- http://www.journals.elsevier.com/gynecologic-oncology-reports
- http://www.elsevier.com
- http://www.sgo.org
- http://www.crown-initiative.org/
- https://doi.org/10.1016/j.ygyno.2019.06.016
- https://doi.org/10.1016/j.ygyno.2019.06.012
- https://doi.org/10.1016/j.ygyno.2019.07.018
- https://doi.org/10.1016/j.ygyno.2019.09.005
- https://doi.org/10.1016/j.ygyno.2019.07.008
- https://doi.org/10.1016/j.ygyno.2019.08.011
- https://doi.org/10.1016/j.ygyno.2019.09.004
- https://doi.org/10.1016/j.ygyno.2019.09.007
- http://www.sciencedirect.com/science/journal/00908258
- https://www.elsevier.com/
- https://www.elsevier.com
- https://www.elsevier.com/legal/privacy-policy
- https://www.elsevier.com/legal/elsevier-website-terms-and-conditions
- https://healthadvance.com/use-of-cookies
- https://www.elsevier.com/wps/find/intro.cws_home/ataglance
- https://www.healthadvance.com/accessibility
- https://www.relx.com/
No hay comentarios:
Publicar un comentario